Previous 10 |
WEST LAFAYETTE, Ind., April 16, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading provider of non-clinical and analytical contract research services, today announced that the C...
Inotiv (NOTV) announces that the company has entered into an agreement to purchase substantially all of the assets of HistoTox Labs, a full-service histopathology contract research organization offering medically relevant non-clinical and clinical services to the pharmaceutical, bio...
WEST LAFAYETTE, Ind., April 13, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading provider of nonclinical and analytical contract research services, today announced that the Co...
Inotiv ([[NOTV]] +0.6%) has collaborated with Japan-based PhoenixBio Co. to provide research services in Inotiv’s U.S. labs using PhoenixBio’s proprietary PXB-mouse research model, a liver-humanized chimeric model used for drug discovery and early development. This par...
WEST LAFAYETTE, Ind., April 06, 2021 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ:NOTV) (the “Company”, “We”, “Our” or “Inotiv”) , a leading provider of nonclinical and analytical contract research services, today announced an agreemen...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...